Daniel J. McKay

The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K

Jacques Yves Gauthier, Nathalie Chauret, Wanda Cromlish et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 473 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Theoretical Calculation of Substituent Effects on the O−H Bond Strength of Phenolic Antioxidants Related to Vitamin E

James S. Wright, David Carpenter, Daniel J. McKay et al. · Journal of the American Chemical Society · 1997 · 254 citations

Natural Sciences, Chemistry, Computational Chemistry +14

Optimizing targeted therapeutic development: Analysis of a colorectal cancer patient population with the BRAF^<i>V600E</i> mutation

Jeanne Tie, Peter Gibbs, Lara Lipton et al. · International Journal of Cancer · 2010 · 226 citations · Full text

Medicine, Molecular Genetics, Oncology +14

Transcription factors mediate long-range enhancer–promoter interactions

Ilias K. Nolis, Daniel J. McKay, Eva Mantouvalou et al. · Proceedings of the National Academy of Sciences · 2009 · 201 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Zelda is differentially required for chromatin accessibility, transcription factor binding, and gene expression in the early <i>Drosophila</i> embryo

Katharine N. Schulz, Eliana R. Bondra, Arbel Moshe et al. · Genome Research · 2015 · 200 citations · Full text

Life Sciences, Developmental Biology, Genetics +17